Structural underfunding and rights erosion risk reversing global HIV/AIDS progress
Original framing: “‘Perilous moment’ threatens to reverse years of gains in HIV/AIDS response” — UN News
Scientific evidence supports the effectiveness of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) in preventing and treating HIV. However, access to these treatments is hindered by pharmaceutical patents and lack of local production capacity in affected regions.
The HIV/AIDS crisis is not just a public health issue but a systemic failure rooted in underfunding, rights erosion, and the marginalization of community-led solutions.
Indigenous and cross-cultural models offer proven alternatives to the dominant biomedical paradigm, while historical patterns reveal the cyclical nature of global health neglect. Scientific evidence supports the effectiveness of prevention and treatment, but access is hindered by pharmaceutical monopolies and structural inequality. To reverse the current trajectory, we must reform global health governance, decentralize funding, and center the voices of those most affected. Only through a rights-based, community-centered approach can we ensure long-term progress in the fight against HIV/AIDS.